Life expectancy low in MEN1 duodenopancreatic neuroendocrine tumor liver metastases

Half of patients with multiple endocrine neoplasia type 1 (MEN1), who developed duodenopancreatic neuroendocrine tumor liver metastases died within 10 years, according to a study inEndocrine Practice.Healio
Source: Society for Endocrinology - Category: Endocrinology Source Type: news